Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand G18
Shenzhen Sijia Pharmaceutical Co., Ltd.
Exhibitor at CPHI South East Asia 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:1 - 24
Company types
Primary activities
Event information
CPHI South East Asia 2026
-
08 Jul 2026 - 10 Jul 2026
-
QSNCC, Bangkok, Thailand
-
Visit us at stand G18
Products Featured at CPHI South East Asia 2026
-
Product Avibactam Sodium
Avibactam sodium is an organic sodium salt that is the monosodium salt of avibactam. Used in combination with ceftazidime pentahydrate for the treatment of complicated urinary tract infections including pyelonephritis. It has a role as an EC 3.5.2.6 (beta-lactamase) inhibitor, an antibacterial drug and an ... -
Product Everolimus
Everolimus is a macrocyclic lactone that is rapamycin in which the hydroxy group attached to the cyclohexyl moiety has been converted into the corresponding 2-hydroxyethyl ether. It is an immunosuppressant and antineoplastic agent. It has a role as an antineoplastic agent, an immunosuppressive agent, a mTO... -
Product Entecavir
Our company is committed to supplying API, advanced intermediates, excipients, chemicals, together with regulatory documentation support like DMF in CTD Format, from R&D to commercial production and cGMP audit service.
-
Product Ferric Carboxymaltose
Our company is committed to supplying API, advanced intermediates, excipients, chemicals, together with regulatory documentation support like DMF in CTD Format, from R&D to commercial production and cGMP audit service.
-
Product Posaconazole
Our company is committed to supplying API, advanced intermediates, excipients, chemicals, together with regulatory documentation support like DMF in CTD Format, from R&D to commercial production and cGMP audit service.




